AACR Group Meetings

Join Us At AACR 2026

April 19 to 20, Guidepoint Insights will be hosting a series of group meetings featuring KOLs who will dive deeper into AACR 2026 updates.

    Sunday, April 19th
    8:30 AM PT (11:30 AM ET) - Dr. Rodabe Amaria
    • Melanoma | Associate Professor for Department of Melanoma Oncology, The University of Texas MD Anderson Cancer Center
    9:30 AM PT (12:30 PM ET) - Dr. Timothy Yap
    • DDR / Synthetic Lethality | Medical Director & Professor, The University of Texas MD Anderson Cancer Center
    11:00 AM PT (2:00 PM ET) - Dr. Poulikos Poulikakos
    • KRAS Pre-Clinical / Early Clinical | Associate Professor, Icahn School of Medicine in Mount Sinai
    1:00 PM PT (4:00 PM ET) - Dr. Konstantin Dragnev
    • NSCLC | Interim Director, Dartmouth Cancer Center
    2:00 PM PT (5:00 PM ET) - Dr. Benjamin Neel
    • Breast Cancer | Co-Founder and Scientific Advisor, Aethon Therapeutics Inc.
    3:00 PM PT (6:00 PM ET) - Dr. Paul Oberstein // *VIRTUAL ONLY*
    • PDAC / CRC | Director of GI Medical Oncology, NYU Langone Hospitals
    4:00 PM PT (7:00 PM ET) - Dr. Sanjay Goel
    • PDAC/CRC/BTC/GEA | Director of Phase I and Investigational Therapeutics, Rutgers Cancer Institute of New Jersey
    Monday, April 20th
    9:00 AM PT (12:00 PM ET) - Dr. Ignacio Garrido-Laguna
    • PDAC / CRC | Chair of Experimental Therapeutics, H. Lee Moffitt Cancer Center & Research Institute Inc.
    10:00 AM PT (1:00 PM ET) - Dr. Tejas Patil
    • NSCLC | Assistant Professor of Medicine in Medical Oncology, School of Medicine, The University of Colorado
    11:00 AM PT (2:00 PM ET) - Dr. Asfar Azmi
    • KRAS Pre-clinical / Early Clinical | Director of Pancreas Cancer Research, Karmanos Cancer Institute
    12:00 PM CT (3:00 PM ET) - Dr. Ryan Corcoran
    • PDAC / CRC | Co-Founder and Member of the Board of Directors at Alterome Therapeutics at Alterome Therapeutics, Inc.
    1:00 PM PT (4:00 PM ET) - Dr. Salman Punekar
    • NSCLC | Assistant Professor of Medicine, NYU Langone Health System
    2:00 PM PT (5:00 PM ET) - Dr. Carlos Arteaga
    • Breast Cancer | Director of the Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center
    3:00 PM PT (6:00 PM ET) - Dr. Jordi Rodón
    • PRMT5 / Synthetic Lethality | Associate Medical Director of Institute for Personalized Cancer Therapy and Clinical Co-Director of Precision Oncology Decision Support Group in Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

    *AACR Group Meetings will be 50 minutes long and available only to attendees. Group meetings are not recorded and transcripts will not be available following the event.

    Geo Debug - for testing only
    HTTP_GEOIP_COUNTRY_CODE: US
    HTTP_GEOIP_REGION: OH
    HTTP_GEOIP_CITY: Columbus